drugset / Trial / NCT01505179
The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether treatment with Ranolazine will improve exercise capacity in patients with Heart Failure with preserved left ventricular ejection fraction, or HFPEF.
Timeline
- Start
- 2011-02
- Primary completion
- 2014-12
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ranolazine | Small molecule | 500 mg | Oral |
| Comparator | Ranolazine | Small molecule | 1000 mg | Oral |